Effect and safety of immunotherapy among elder patients (age ≥ 65) with recurrent or metastatic nasopharyngeal carcinoma

Effect and safety of immunotherapy among elder patients (age ≥ 65) with recurrent or metastatic nasopharyngeal carcinoma

Abstract Background The use of immune checkpoint inhibitors (ICIs) combined with chemotherapy constitutes the first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (RM-NPC). However, elderly patients are underrepresented in the majority of related clinical trials. Patients and me...

Full description

Saved in:
Bibliographic Details
Main Authors: Rui-Ling Xie, Wu-Lin Cai, Yan-Feng Ouyang, Ye-Hao Zou, Rui Sun
Format: Article
Language:English
Published: BMC 2025-04-01
Series:BMC Cancer
Subjects:
Nasopharyngeal carcinoma
Geriatric oncology
Recurrence
Metastasis
Local therapy
Survival
Online Access:https://doi.org/10.1186/s12885-025-14108-w
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items